The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
Abstract
Activation of protein kinase C (PKC) is implicated as an important mechanism by which diabetes causes vascular complications. We have recently shown that a PKC β inhibitor ameliorates not only early diabetes‐induced glomerular dysfunction such as glomerular hyperfiltration and albuminuria, but also overexpression of glomerular mRNA for transforming growth factor β1 (TGF‐βΙ) and extracellular matrix (ECM) proteins in streptozoto‐cin‐induced diabetic rats, a model for type 1 diabetes. In this study, we examined the long‐term effects of a PKC β inhibitor on glomerular histology as well as on biochemical and functional abnormalities in glomeruli of db/db mice, a model for type 2 diabetes. Administration of a PKC β inhibitor reduced urinary albumin excretion rates and inhibited glo‐merular PKC activation in diabetic db/db mice. Administration of a PKC β inhibitor also prevented the mesangial expansion observed in diabetic db/db mice, possibly through attenuation of glomerular expression of TGF‐β and ECM proteins such as fibronectin and type IV collagen. These findings provide the first in vivo evidence that the long‐term inhibition of PKC activation in the renal glomeruli can ameliorate glomerular pathologies in diabetic state, and thus suggest that a PKC β inhibitor might be an useful therapeutic strategy for the treatment of diabetic nephropathy.—Koya, D., Haneda, M., Nakagawa, H., Isshiki, K., Sato, H., Maeda, S., Sugimoto, T., Yasuda, H., Kashiwagi, A., Ways, D. K., King, G. L., Kikkawa, R. Amelioration of accelerated diabetic mesangial expansion by treatment with A PKC b inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 14, 439–447 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Self-citationStructural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Hyperglycemic Pseudohypoxia and Diabetic Complications
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Den Enden, M. V., Kilo, C., & Tilton, R. G. (1993) · Diabetes · doi:10.2337/diab.42.6.801 · Cited by 1,105
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Self-citation(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.10.006 · Cited by 1,080
Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study
Andersen, A. R., Christiansen, J. S., Andersen, J. K., Kreiner, S., & Deckert, T. (1983) · Diabetologia · doi:10.1007/bf00284458 · Cited by 1,067
Flier, J. S., Underhill, L. H., Greene, D. A., Lattimer, S. A., & Sima, A. A. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161007 · Cited by 897
Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
The changing natural history of nephropathy in type I Diabetes
Krolewski, A. S., Warram, J. H., Christlieb, A. R., Busick, E. J., & Kahn, C. R. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90284-0 · Cited by 777
Sharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566
Self-citationSharma, K., & Ziyadeh, F. N. (1995) · Diabetes · doi:10.2337/diab.44.10.1139 · Cited by 554
Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., & King, G. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119503 · Cited by 536
Self-citationMesangial Expansion as a Central Mechanism for Loss of Kidney Function in Diabetic Patients
Steffes, M. W., Østerby, R., Chavers, B., & Mauer, S. M. (1989) · Diabetes · doi:10.2337/diab.38.9.1077 · Cited by 440
Craven, P. A., & DeRubertis, F. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114066 · Cited by 319
Cellular events in the evolution of experimental diabetic nephropathy
Young, B. A., Johnson, R. J., Alpers, C. E., Eng, E., Gordon, K., Floege, J., Couser, W. G., & Seidel, W. T. S. A. F. S. K. (1995) · Kidney International · doi:10.1038/ki.1995.139 · Cited by 318
Glomerular Structure in Nonproteinuric IDDM Patients With Various Levels of Albuminuria
Fioretto, P., Steffes, M. W., & Mauer, M. (1994) · Diabetes · doi:10.2337/diab.43.11.1358 · Cited by 297
Derubertis, F. R., & Craven, P. A. (1994) · Diabetes · doi:10.2337/diabetes.43.1.1 · Cited by 275
High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures
Ayo, S. H., Radnik, R., Garoni, J. A., Troyer, D. A., & Kreisberg, J. I. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.4.f571 · Cited by 255
SUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
Haneda, M., Araki, S.-I., Togawa, M., Sugimoto, T., Motohide, I., & Kikkawa, R. (1997) · Diabetes · doi:10.2337/diab.46.5.847 · Cited by 248
Self-citationBallard, D. J., Humphrey, L. L., Melton, L. J., Frohnert, P. P., Chu, C.-P., O'Fallon, W. M., & Palumbo, P. J. (1988) · Diabetes · doi:10.2337/diab.37.4.405 · Cited by 232
Craven, P. A., Davidson, C. M., & DeRubertis, F. R. (1990) · Diabetes · doi:10.2337/diab.39.6.667 · Cited by 227
Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.
Koya, D., Lee, I. K., Ishii, H., Kanoh, H., & King, G. L. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v83426 · Cited by 218
Self-citationDerubertis, F. R., & Craven, P. A. (1994) · Diabetes · doi:10.2337/diab.43.1.1 · Cited by 212
Polyantigenic Expansion of Basement Membrane Constituents in Diabetic Nephropathy
Falk, R. J., Scheinman, J. I., Mauer, S. M., & Michael, A. F. (1983) · Diabetes · doi:10.2337/diab.32.2.s34 · Cited by 208
Kim, S. J., Denhez, F., Kim, K. Y., Holt, J. T., Sporn, M. B., & Roberts, A. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47311-0 · Cited by 183
Sharma, K., & Ziyadeh, F. N. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.267.6.f1094 · Cited by 181
Glomerular filtration surface in type I diabetes mellitus
Ellis, E. N., Steffes, M. W., Goetz, F. C., Sutherland, D. E. R., & Mauer, S. M. (1986) · Kidney International · doi:10.1038/ki.1986.82 · Cited by 172
Sassone‐Corsi, P., Ransone, L. J., & Verma, I. M. (1990) · PubMed · Cited by 153
Cohen, M. P., Sharma, K., Jin, Y. S., Hud, E., Wu, V.-Y., Tomaszewski, J., & Ziyadeh, F. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117926 · Cited by 148
Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians
Kunzelman, C. L., Knowler, W. C., Pettitt, D. J., & Bennett, P. H. (1989) · Kidney International · doi:10.1038/ki.1989.39 · Cited by 137
Unchanged Incidence of Diabetic Nephropathy in IDDM Patients
Rossing, P. R., Rossing, K., Jacobsen, P. K., & PARVING, H.-H. D. (1995) · Diabetes · doi:10.2337/diab.44.7.739 · Cited by 127
Geiser, A. G., Kim, S. J., Roberts, A. B., & Sporn, M. B. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.84 · Cited by 124
Sharma, K., Danoff, T. M., DePiero, A. D., & Ziyadeh, F. N. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1156 · Cited by 121
Evidence for Existence of Polyol Pathway in Cultured Rat Mesangial Cells
Kikkawa, R., Umemura, K., Haneda, M., Arimura, T., Ebata, K., & Shigeta, Y. (1987) · Diabetes · doi:10.2337/diab.36.2.240 · Cited by 113
Self-citationYoshimura, A., Gordon, K., Alpers, C. E., Floege, J., Pritzl, P., Ross, R., Couser, W. G., Bowen‐Pope, D. F., & Johnson, R. J. (1991) · Kidney International · doi:10.1038/ki.1991.234 · Cited by 110
Kikkawa, R., Haneda, M., Uzu, T., Koya, D., Sugimoto, T., & Shigeta, Y. (1994) · Diabetologia · doi:10.1007/bf00404342 · Cited by 109
Self-citationBabazono, T., Kapor-Drezgic, J., Dlugosz, J. A., & Whiteside, C. I. (1998) · Diabetes · doi:10.2337/diabetes.47.4.668 · Cited by 96
Nakao, N., Hiraiwa, N., Yoshiki, A., Ike, F., & Kusakabe, M. (1998) · Europe PMC (PubMed Central) · Cited by 95
Dean, D. C., McQuillan, J. J., & Weintraub, S. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39800-x · Cited by 74
Zhu, D., Kim, Y., Steffes, M. W., Groppoli, T. J., Butkowski, R. J., & Mauer, S. M. (1994) · Kidney International · doi:10.1038/ki.1994.55 · Cited by 73
Peten, E. P., Striker, L. J., Carome, M. A., Elliott, S. J., Yang, C., & Striker, G. E. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1571 · Cited by 70
Hugo, C., Hugo, C., Pichler, R. H., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118697 · Cited by 69
The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy
Cohen, M. P., Sharma, K., Guo, J., Eltayeb, B. O., & Ziyadeh, F. N. (1998) · Nephron Experimental Nephrology · doi:10.1159/000020527 · Cited by 48
Murphy, M., McGinty, A., & Godson, C. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199809000-00013 · Cited by 33
Early immunopathologic events in experimental diabetic nephropathy: A study in mice
Lee, S. M., & Graham, A. R. (1980) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(80)90030-1 · Cited by 26
Cited by
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
Self-citation
Metadata
- Authors
- KOYA, D., HANEDA, M., NAKAGAWA, H., ISSHIKI, K., SATO, H., MAEDA, S., SUGIMOTO, T., YASUDA, H., KASHIWAGI, A., WAYS, D. K., KING, G. L., & KIKKAWA, R.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-03
- Volume
- 14
- Issue
- 3
- Pages
- 439-447
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1932654578
- Cited by
- 427
- References
- 54
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.